Article - 24/05/2010 Nose drops replace transplantation Dr. Lusine Danielyan a scientist from Tübingen has developed a method that enables her to administer therapeutic cells for the treatment of neurodegenerative diseases to animals without requiring syringes or surgery. The animals simply snort the cell suspension. In September 2009 Danielyan received the Baden-Württemberg Research Prize for Alternative and Complementary Methods to Animal Testing for her development.https://www.gesundheitsindustrie-bw.de/en/article/news/nose-drops-replace-transplantation
Article - 24/05/2010 Alternative CAM: chicken eggs to precede mouse experiments Researchers who test whether in vitro results can be transferred to living organisms prefer to use mice rats or rabbits. Many questions can be answered using the chorioallantoic membrane CAM of fertilised chicken eggs an alternative model to animal experiments that provides rapid results and only costs 50 cents per egg.https://www.gesundheitsindustrie-bw.de/en/article/news/alternative-cam-chicken-eggs-to-precede-mouse-experiments
Article - 15/04/2010 Bone-hard basic research for an ageing society Osteoporotic bones not only break very easily, they also heal badly when a fracture occurs. A fractured femur neck might mean that elderly patients have to remain bedridden for a long period and maybe even need nursing care. Fractures that heal badly, in combination with other diseases, frequently lead to a fatal outcome. A panregional team of researchers, including researchers from Ulm, has been working together since 2007 on basic research into…https://www.gesundheitsindustrie-bw.de/en/article/news/bone-hard-basic-research-for-an-ageing-society
Article - 28/03/2010 Acrovis biostructures: because the beginning of a process is crucial Targeted substance design using an advanced platform technology that takes into account the natural dynamics of pharmaceutical substances and targets early on during the discovery process – this is what the Ulm-based biopharmaceutical company Acrovis biostructures GmbH offers. Acrovis has all the instruments needed to be able to optimally determine the structure of pharmaceutical substances.https://www.gesundheitsindustrie-bw.de/en/article/news/acrovis-biostructures-because-the-beginning-of-a-process-is-crucial
Article - 22/02/2010 Immune system discovers mould fungi through surface structures Mould fungus spores which are found in air aerosols are constantly being taken up in the air we inhale. As a rule this poses no danger to healthy people. However depending on the quantity of spores inhaled and the duration of exposure mould fungi could possibly lead or contribute to lung diseases and allergies. Dr. Mardas Daneshian and his team at the University of Constance are focusing on the immunostimulatory capacity of fungal spores. The…https://www.gesundheitsindustrie-bw.de/en/article/news/immune-system-discovers-mould-fungi-through-surface-structures
Press release - 22/02/2010 AgenoLab GmbH: Improved quality of life for patients with chronic wounds Since its foundation three years ago, AgenoLab GmbH & Co. KG in Stuttgart has become a leading service provider in the area of life sciences and biotechnology. The company’s cell culture technology unit focuses on the preparation of cells that can largely eliminate the need for animal testing. In the area of regenerative medicine, AgenoLab GmbH concentrates on the growth of skin cells as transplants for patients suffering from burns and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/agenolab-gmbh-improved-quality-of-life-for-patients-with-chronic-wounds
Article - 11/02/2010 Johanna Schanz: Liver model as an alternative to animal experiments Blood vessels of a piece of pig’s intestine are used as carrier material for the IGB’s liver model and the cells seeded on the blood vessels stem from human biopsies. Dr. Johanna Schanz from the Fraunhofer IGB used this combination to produce her doctoral thesis which led to impressive results: a functional system of blood vessels in a biological carrier structure. Schanz’s outstanding thesis results have led to the creation of a liver model for…https://www.gesundheitsindustrie-bw.de/en/article/news/johanna-schanz-liver-model-as-an-alternative-to-animal-experiments
Article - 28/01/2010 Liver cell transplantation for the treatment of innate urea cycle defects Liver transplantation is the only life-saving therapy available to patients suffering from genetic defects of the urea cycle. However, newborns cannot be transplanted with a donor liver. The injection of liver cell suspensions into the liver of sick babies through the portal vein can substitute the lack of enzyme activity, hence preventing brain damage until such time as liver transplantation becomes possible.https://www.gesundheitsindustrie-bw.de/en/article/news/liver-cell-transplantation-for-the-treatment-of-innate-urea-cycle-defects
Article - 25/01/2010 Intelligent use of suitable biomarkers How quickly does a pharmaceutical substance exert its effect? What mechanisms does it use to exert its effect on people and how long does it remain active? In a team headed by Prof. Dr. Martin Elmlinger Nycomed GmbH has developed an efficient biomarker discovery concept specially adapted to the companys requirements and designed to clarify such questions. The concept is specifically geared to the phases and requirements of the companys projects.…https://www.gesundheitsindustrie-bw.de/en/article/news/intelligent-use-of-suitable-biomarkers
Article - 14/12/2009 Clever surveillance system keeps yeast in check The spectrum of human diseases (mycoses) caused by fungi ranges from trivial nail infections to life-threatening systemic infections. The latter are mainly caused by Candida albicans. The dermatologist Prof. Dr. med. Martin Schaller from Tübingen is investigating how this fungus, which is actually part of the normal microbial flora of humans, becomes a pathogen. At the same time, he is looking into the role the patient’s immune system plays in…https://www.gesundheitsindustrie-bw.de/en/article/news/clever-surveillance-system-keeps-yeast-in-check
Article - 28/10/2009 Worn down and financially exhausted, but more popular than ever When academic toxicologists in a German state join forces, it is virtually headline news. This is because the discipline is on the red list. Only in Baden-Württemberg does the number of toxicologists at university institutes justify the joining of forces. The ironic thing about this is that the competence of the rare species ”toxicologicus” is in greater demand than ever. https://www.gesundheitsindustrie-bw.de/en/article/news/worn-down-and-financially-exhausted-but-more-popular-than-ever
Press release - 16/09/2009 Praise and prize for researchers from Ulm Three prizes have recently been awarded to researchers for their outstanding achievements in the research of methods that help reduce the number of animal experiments conducted, contribute to elucidating cellular processes and improve patient treatment. This article features the three prizewinners and their achievements.https://www.gesundheitsindustrie-bw.de/en/article/press-release/praise-and-prize-for-researchers-from-ulm
Press release - 15/09/2009 Nose drops rather than transplantation – an alternative and complementary method to animal testing On 14th September 2009 the physician Dr. Lusine Danielyan from Tübingen was awarded the Förderpreis Ersatz- und Ergänzungsmethoden zum Tierversuch des Landes Baden-Württemberg Prize for alternative and complementary methods to animal testing in Stuttgart. The young scientist who works in the Department of Clinical Pharmacology at the Institute of Experimental and Clinical Pharmacology and Toxicology at the University Hospital of Tübingen has…https://www.gesundheitsindustrie-bw.de/en/article/press-release/nose-drops-rather-than-transplantation-an-alternative-and-complementary-method-to-animal-testing
Press release - 08/09/2009 Angiogenesis as a key for tissue engineering The German Research Foundation is to fund a research priority of the Department of Plastic Surgery at the Freiburg University Medical Centre. Researchers around the world working in the area of regenerative medicine are all equally hopeful of generating tissue replacements using modern tissue engineering. The development of tissue cells on carrier materials seems quite promising. However, tissue-engineered implants are often rejected by patients…https://www.gesundheitsindustrie-bw.de/en/article/press-release/angiogenesis-as-a-key-for-tissue-engineering
Dossier - 26/08/2009 Model organisms Given that everything is very individual in nature, how can a biologist come up with general statements about how life functions? The answers can only be found using models that represent the entire whole. Modern research uses representative species from the kingdom of bacteria, fungi, plants and animals to glean information about fundamental biological principles. How can the knowledge gained be transferred to other organisms, including humans?…https://www.gesundheitsindustrie-bw.de/en/article/dossier/model-organisms
Article - 21/08/2009 Patenting and clinical trials go hand in hand Back when he was doing his degree thesis at the German Cancer Research Centre in Heidelberg the immunologist Prof. Peter Öhlschläger who now works at the University of Constance laid down the basic principles for developing an artificial gene for the treatment of cervical cancer. Prof. Öhlschläger is currently in the process of filing a patent for DNA vaccines for HPV. In the following interview the scientist says that the greatest challenges are…https://www.gesundheitsindustrie-bw.de/en/article/news/patenting-and-clinical-trials-go-hand-in-hand
Article - 30/06/2009 More targeted treatment of the brain network “Casting out the demons with the ruler of the demons” – is what the majority of neuroactive drugs still do. A group under the leadership of Dr. Ralf Meyer at the University Medical Centre in Freiburg is investigating why substances used to treat epilepsy or depression have a negative effect on many patients. Their research shows that the drugs interact with the hormonal system, resulting in undesired side effects. Meyer and his team of…https://www.gesundheitsindustrie-bw.de/en/article/news/more-targeted-treatment-of-the-brain-network
Press release - 24/06/2009 Artificial liver for drug testing The liver is one of the most important metabolic organs in humans. Johanna Schanz and Heike Mertsching, two scientists from Fraunhofer have developed a model of the liver that is both viable outside the body and suitable for testing drugs. For their work, the two researchers have been awarded the Technology for People award, along with a cheque for 10,000 euros. https://www.gesundheitsindustrie-bw.de/en/article/press-release/artificial-liver-for-drug-testing
Press release - 22/06/2009 Many animal experiments are superfluous Researchers at the Esslingen University of Applied Sciences are working on an alternative to the large number of animal experiments that are still being carried out. Researchers under the leadership of Prof. Dr. Bettina Weiß have received a grant from the Landesstiftung Baden-Württemberg foundation for work on this particular research area.https://www.gesundheitsindustrie-bw.de/en/article/press-release/many-animal-experiments-are-superfluous
Article - 05/04/2009 JOTEC – artificial blood vessel specialist JOTEC GmbH a medical device company based in Hechingen has a broad range of solutions on offer for the therapy of vascular diseases including artificial blood vessels and stentgrafts and is an international leader in this field. The company not only produces traditional vascular grafts from high-quality plastics but also absorbable bioartificial vascular grafts and cell-coated grafts made from biomaterials. Such an approach is currently unique in…https://www.gesundheitsindustrie-bw.de/en/article/news/jotec-artificial-blood-vessel-specialist
Article - 10/02/2009 Janine Reis – improving the acquisition of motor skills Putting a teaspoon of sugar into a cup of coffee would appear to be a very trivial action. However the coordination of hand and fingers becomes a virtually insurmountable challenge for people who have suffered a stroke. Dr. Janine Reis assistant doctor and researcher in the Department of Neurology at the Freiburg Medical School is investigating ways to improve the acquisition of fine motor skills.https://www.gesundheitsindustrie-bw.de/en/article/news/janine-reis-improving-the-acquisition-of-motor-skills
Article - 02/02/2009 CureVac enters premier biotech league with new cancer vaccine At present active immunotherapy seems to produce the best results in the treatment of cancer. The Tübingen-based biotech company CureVac is now hoping to achieve a breakthrough in cancer therapy with a worldwide unique vaccine. The first clinical trials have recently commenced.https://www.gesundheitsindustrie-bw.de/en/article/news/curevac-enters-premier-biotech-league-with-new-cancer-vaccine
Press release - 08/01/2009 ILM – Alternative models to replace animal experiments Since the beginning of the last century, fertilised chicken eggs have been an established model system and are nowadays often used as an alternative to animal experiments. The test model involves the use of the outer, strongly vascularised amnion (the so-called chorioallantoic membrane, CAM) which surrounds the embryo and is used for gas exchange during embryonic development.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-alternative-models-to-replace-animal-experiments
Article - 07/12/2008 Production line for artificial skin A fully automated process is set to improve the production of artificial tissue medical scientists can perform transplants with skin produced in the laboratory. This tissue is also suitable for testing chemicals at a low cost without requiring animal experiments. https://www.gesundheitsindustrie-bw.de/en/article/news/production-line-for-artificial-skin
Article - 19/11/2008 cr.appliance- integrated concepts in drug development Karen Grave-Hermann and Dr. Robert Hermann founded cr.applications in 2003. The two specialists who have wide-ranging experience in drug development talked to Michael Statnik about current trends in their field and about the development of the German biotech sector.https://www.gesundheitsindustrie-bw.de/en/article/news/cr-appliance-integrated-concepts-in-drug-development